abstract: Hydatidiform moles (HMs) most often occur sporadically and are either diploid androgenetic or triploid. The very rare familial recurrent HMs (FRHMs) have been related to NLRP7 and C6orf221 mutations in the mother. FRHMs are most often diploid with both maternal and paternal origin of the molar genome. We have screened a cohort of 11 women with diploid HMs with biparental contributions to the molar genome with regard to mutations in NLRP7, NLRP2, the NLRP gene most homologous to NLRP7, and C6orf221. This was done in order to reveal if mutations in the mentioned genes play a major role in development of non-recurrent biparental moles. Recently, we have shown that eight of these diploid moles consist of two different cell lines. Only one woman had a mutation in the coding DNA sequence of NLRP7, which most likely contributed to HM development. This woman had non-mosaic repeated moles, and she was the only woman in our cohort with FRHM. We found no unequivocal pathogenic mutations in NLRP2 or C6orf221. Our observations suggest that although NLRP7 and C6orf221 mutations are related to diploid biparental FRHMs, neither of these genes, nor NLRP2, are related to diploid HMs with biparental contributions to the molar genome, in general.
Introduction
Hydatidiform mole (HM) is an abnormal human pregnancy. A molar pregnancy is characterized by non-existent, or abnormal, embryonic development, trophoblastic hyperplasia and hydropic enlargement of the chorionic villi. HMs are divided into two types, complete HM (CHM) and partial HM (PHM) based on the histopathological examination of the mole.
Most CHMs are diploid androgenetic (PP) and PHMs are mostly triploid diandric (PPM) (Jacobs et al., 1982; Paradinas et al., 1996; Fukunaga, 2001) . Partial moles can be formed by two different mechanisms, fertilization of an oocyte by two spermatozoa or by fertilization of an oocyte by a diploid spermatozoon (Ulug et al., 2004; Chatzimeletiou et al., 2011) .
However rare cases of HM have other genetic constitutions, for instance biparental diploidy (PM) (Vejerslev et al., 1991; Helwani et al., 1999; Fisher et al., 2000; Kou et al., 2008) and mosaicism between a diploid androgenetic and a diploid biparental cell line (PP/PM) (Ford et al., 1986; Weaver et al., 2000; Makrydimas et al., 2002; Shiina et al., 2002; Hoffner et al., 2008; Deveault et al., 2009; Sunde et al., 2011) . We have recently demonstrated that a substantial fraction of diploid molar conceptuses showing biparental contributions to the molar genome, actually are mosaics: PP/PM HMs. And we have shown that a likely pathogenetic mechanism for this mosaicism is early cleavage abnormality (Sunde et al., 2011) .
HM most often occurs sporadically; however, some women experiences recurrent mole development and these moles have been reported to be mostly PM HMs (Vejerslev et al., 1991; Helwani et al., 1999; Fisher et al., 2000) . A number of cases of women carrying an autosomal recessive predisposition to molar conceptions due to mutations in NLRP7 have been reported (Hodges et al., 2003; Murdoch et al., 2006; Kou et al., 2008; Hayward et al., 2009; Wang et al., 2009; Muhlstein et al., 2011) . However, Deveault et al. (2009) reported on a large variety of genomic constitutions in molar conceptuses of women carrying mutations in NLRP7 and suggested that mutations in this gene also predispose to early embryo cleavage abnormalities. One recent study has linked another gene to HM development. C6orf221 mutations were found in four individuals with familial biparental HM from three different families (Parry et al., 2011) . The expression pattern of C6orf221 is similar to that of NLRP7 (Zhang et al., 2008; Parry et al., 2011) and is a typical expression pattern for oocyte-specific genes (Hayward et al., 2003; Huntriss et al., 2006; Zheng and Dean, 2007; Ohsugi et al., 2008) . C6orf221 is suspected to participate in a complex similar to the NLRP7 complex during human oogenesis and/or early embryogenesis (Parry et al., 2011) .
The facts that NLRP7 mutations are most often observed in women with familial recurrent HM (FRHM) and that FRHMs generally are PM moles led us to wonder if the etiology of PM moles in general is related to NLRP7, NLRP2 the NLRP gene most homologous to NLRP7, or C6orf221 mutations. We report here the results of a comprehensive screening for mutations in NLRP7, NLRP2 and C6orf221 in mothers of PP/PM HMs and in mothers of PM HMs. Our observations indicate that whereas mutations in both alleles of NLRP7 may be a cause of familial, repeated diploid biparental moles, neither mutations in this gene, nor in NLRP2, or C6orf221 are likely to play a central role in the formation of mosaic moles or non-familial diploid biparental moles.
Results

NLRP7
We analysed blood samples from all 11 women in a Danish cohort of consecutive mothers to present with diploid HMs showing biparental alleles. The 11 women included 8 women with PP/PM HMs and 3 women with PM HMs (Sunde et al., 2011) .
The screening revealed one previously reported NLRP7 mutation (Table I) Six additional DNA variants in the coding DNA sequence (CDS) of NLRP7 were found in one or both alleles of the individual women (Table I) . Four of these variants are silent and all six have been reported to have allele frequencies of 11.1% or above (dbSNP 135, UCSC).
NLRP2
As NLRP7 appears to originate from a NLRP2/7 ancestor gene in primates, we also screened the 11 women for NLRP2 mutations.
We found 12 different variations in the CDS of NLRP2 (Supplementary data, Table SI ). Seven of these are silent. One missense variation A.G found at position c.2231 was observed in a homozygous state in patient 131, who is homozygous for a pathogenic mutation in NLRP7. The variant at this position changes glutamine to arginine in the NLRP2 protein. c.2231 A.G is not mentioned in the SNP 135, UCSC database.
The remaining four changes were missense variations in heterozygous states (besides in patient 131 who is homozygous for all four variations). The missense change at position c.593 has been found in one-fourth of the European population (dbSNP, NCBI), and is thus unlikely to cause a high risk of molar pregnancy. The variant at position c.991 (G) is found at the same position in the reference sequence of NLRP7. The variation causes substitution of isoleusine with valine but these two amino acids are very similar chemically. Furthermore, valine is found at the same position in NLRP7 and mouse NLRP2. The allele occurs with a frequency of 4.2% and we do not expect this variation to be involved in the etiology of HM formation. The missense variation at position c.2041 causing substitution of leucine with isoleucine, has been reported to public databases like UCSC, Human Genome Browser and SNP, NCBI but without pathogenic consequences. The allele occurs with a frequency of 1.9% and leucine and isoleucine are chemically very similar. We do not expect the change to be involved in the etiology of HM formation. The last variation at c.3086 has an allele frequency of 37.4% and is likewise not likely to be a pathogenic change.
C6orf221
We found two missense variations in the CDS of C6orf221, c.289 G.C and c.602 C.G (Supplementary data, Table SII ). Both variants are well known SNPs with allele frequencies of 33.3 and 47.5%, respectively (dbSNP 135, UCSC).
Materials and Methods
Patients and samples
In the Danish Mole Project, samples from conceptuses presenting with vesicular villi on ultrasound or by visual inspection of the aborted tissue, are collected consecutively. The histopathology is revised blindly with respect to the results of the genetic analyses. The Danish Mole Biobank contains 309 samples collected in the period April 1986-June 2003. At the histopathological revision, 270 were classified as originating from HMs. The genetic constitution was analyzed by karyotyping, flow cytometric assessment of the nuclear DNA contents and analysis of polymorphic DNA markers. A total of 162 HMs were diploid, of which 151 were diploid androgenetic (PP), whereas 11 showed biparental DNA markers. Eight of the diploid moles with biparental contributions to the molar genome were mosaics, in that two different cell lines were identified, an androgenetic cell line and a biparental cell line (PP/PM), whereas 3 of the 11 moles contained cells with biparental genomes, only (PM) (Niemann et al., 2007; Sunde et al., 2011) . The mothers of 10 of the diploid moles with biparental alleles are Danish and have had a single molar pregnancy. One mother (Patient 131) is Lebanese with consanguineous parents and has FRHM. Observations in this family has been published previously (Vejerslev et al., 1991; Sunde et al., 1993; Helwani et al., 1999; Murdoch et al., 2006) .
The biparental origin of the genome in each HM has previously been documented using a panel of at least 10 microsatellite markers (D21S1435, X22, D13S258, D18S51, D18S391, D18S978, D21S11, D21S1411, D13S634, D13S305, D13S742, D21S1270, D18S386, D13S499, D18S535) (Sunde et al., 2011) .
Clinical data were obtained from a questionnaire filled in by the parents of the moles, and from the medical records. A central histopathological revision has been performed previously (Niemann et al., 2007) .
The regional Committee on Biomedical Research Ethics approved the study and all patients gave informed consent.
PCR and sequencing
NLRP7
DNA was amplified by PCR using 15 primer pairs designed to cover the 11 exons and flanking intronic sequences of NLRP7. The coding exons 2 -11 as well as the non-coding exon 1 were sequenced.
Primer sequences were adapted from Wang et al., 2009 (Supplementary data, Table SIII).
NLRP2
DNA was amplified by PCR using 16 primer pairs designed to cover the 14 exons and flanking intronic sequences of NLRP2. The coding exons 2 -14 as well as the non-coding exon 1 were sequenced (Supplementary data, Table SIV for primer sequences).
C6orf221
DNA was amplified by PCR using three primer pairs designed to cover the coding sequence (CDS) and the flanking intronic sequences of C6orf221.
Primer sequences were adapted from Parry et al. (2011) , (Supplementary data, Table SV ). NLRP7, NLRP2 and C6orf221 in diploid biparental HMs PCR conditions were: 3 min at 948C, followed by 35 cycles of (1 min at 948C, 1 min at 588C/608C, 1 min at 728C) and final extension for 10 min at 728C. The annealing temperature used in the PCR was 588C for all primer pairs except for exon 1, 4C, 4D and 8 (NLRP7) and for exons 10 and 7.1 (NLRP2) for which the annealing temperature was 608C and for exons 5 and 6 (NLRP2) for which the annealing temperature was 578C.
NLRP7 and NLRP2
PCR products were treated with Exonuclease I, Escherichia coli and FastAP, Thermosensitive Alkaline Phosphatase (Fermentas, St. Leon-Rot, Germany) for 75 min at 378C and 15 min at 858C. The PCR products were precipitated using sodium-acetate and ethanol or isopropanol and sequenced in forward and reverse direction using BigDye Terminator v1.1 (Applied Biosystems, Carlsbad, USA) and ABI Genetic Analyzer 3130XL (Applied Biosystems).
C6orf221
PCR components were: PCR Amplification Kit from Takara Bio, Japan [TaKaRa Taq DNA polymerase, 10× PCR buffer (with 15 mM MgCl 2 ) and dNTP mixture (2.5 mM of each dNTP)]. Additional PCR reagents were: RNase-free H 2 O, 10 mM of each primer and 50 ng DNA.
PCR conditions using Touchdown PCR were: 5 min at 948C, followed by 15 (exons 1+3)/11 (exon 2) cycles of [30 s at 948C, 45 s at 67 -538C (exons 1+3)/70-598C (exon 2) (one degree decrease every cycle), 2 min at 728C], hereafter 20 cycles of [30 s at 948C, 45 s at 538C (exons 1+3)/598C (exon 2), 2 min at 728C] and final extension for 5 min at 728C.
PCR products were purified using MinElute PCR Purification Kit from Qiagen and sequenced in forward and reverse direction at BGI, Shenzhen, China.
Mutation analysis
The numbering of the NLRP7, NLRP2 and C6orf221 sequences is according to Genbank accession numbers NM_001127255.1, NM_017852 and NM_001017361.2, respectively. Mutation numbering is based on the cDNA sequence with A of the translation start codon ATG as nucleotide +1. Protein numbering begins with start codon ATG as amino acid +1.
The sequencing results were analyzed with ChromasPro software (version 1.5, Technelysium Pty Ltd) Discussion NLRP7 mutations have been suggested to be causative of a major part of recurrent HMs (Murdoch et al., 2006; Kou et al., 2008; Wang et al., 2009) and recurrent moles are often diploid and classified as biparental as they show both paternal and maternal alleles (Deveault et al., 2009) . It would thus be tempting to suggest that mutations in NLRP7 cause 'diploid moles with biparental contributions to the molar genome', in general. Recently, however, it has become clear that 'diploid HMs with biparental contributions to the molar genome' consists of at least two different entities: Genuine diploid biparental HMs (PM HMs) and mosaics with one cell line being androgenetic and the other biparental (PP/PM HMs) (Sunde et al., 2011) .
The consecutively collected samples of HMs and their mothers in The Danish Mole Biobank, allowed for the first time the analysis of an unbiased cohort of mothers to diploid moles showing biparental alleles. The 11 women analyzed, constitute the total number of women identified with diploid moles having biparental alleles in the western part of Denmark from 1986 to 2003. Three of the 11 women had genuine biparental moles (PM moles), whereas eight women had mosaic moles (PP/PM moles).
By the screening of NLRP7, we found one likely deleterious mutation: As previously reported, patient 131 is homozygous for the splice site mutation c.[352+1G.A]+[352+1G.A]. The mutation results in two isoforms: one creating a premature stop codon and one resulting in the exclusion of exon 3. Furthermore, the mutation co-segregated with the 'mole-maker' phenotype in the family of Patient 131 (Murdoch et al., 2006) . Patient 131 has had several PM moles and FRHM.
Six additional DNA variants of NLRP7 were found, none of which was likely responsible for the mole conceptuses. Deveault et al. (2009) reported that conceptuses of two patients with NLRP7 variants showed in vitro early cleavage abnormalities and proposed that NLRP7 mutations may increase the risk of androgenetic HMs via a two-hit mechanism where the rate of mosaicism for cell lines with various genetic constitutions is increased and the selection against androgenetic cells is reduced. Our results do not support this proposal as all analysed pregnancies of the woman with unequivocal NLRP7 mutations were diploid biparental with no sign of mosaicism (Sunde et al., 1993) . Furthermore, in the eight women with mosaic HMs, including an androgenetic cell line, we did not discover any likely pathogenic NLRP7 mutations.
NLRP2 has been associated with another imprinting disorder: Beckwith -Wiedemann syndrome (BWS). BWS share some similarities with HMs: The placenta can be hydropic and most cases of BWS are associated with a surplus, or hyperfunction, of paternally expressed genes relative to maternally expressed genes in the imprinted region of 11p15.5. Most often this is caused by abnormal imprinting, point mutations or duplications/deletions in this region (Maher and Reik, 2000) . However, in the mother of two children with BWS, mutations were identified in both alleles of NLRP2 .
For both NLRP2 and NLRP7, recessive germ line mutations in the mother have been associated with the phenotype of the 'offspring': BWS and HM, respectively. NLRP2 is connected to NLRP7 in several ways: Tian et al. (2009) analyzed the evolutional and functional divergence of NLRP genes and found evidence, suggesting the origin of NLRP7 from a duplication of a NLRP2/7 ancestor in primates. An alignment between the human NLRP7 and human NLRP2 genes shows a high similarity between the two genes (alignment not shown). Moreover, NLRP2 and NLRP7 show almost identical expression patterns in human oocytes and embryos, different from the other NLRP genes, suggesting that NLRP2 and NLRP7 have similar roles in embryonic development (Zhang et al., 2008) . The two proteins, NLRP2 and NLRP7 have identical structure and 62% amino acid identity (alignment not shown).
In the patient that is homozygous for a pathogenic mutation in NLRP7 (patient 131), we found homozygosity for the variation A.G at position c.2231 in NLRP2, changing glutamine to arginine at position 884 in the protein. The amino acid at this position is not conserved in NLRP2; and in mouse NLRP2 there is a serine at this position (alignment not shown). Patient 131 has consanguineous parents and is homozygous at most positions of NLRP2 and NLRP7. Although we cannot exclude that this variation in NLRP2 confers a risk of molar pregnancies, the fertility history of this woman is readily explained by the mutation in NLRP7. Thus, NLRP2 c.2231A.G most likely is a nonpathogenic variation.
We observed 11 other base substitutions in NLRP2 (Supplementary data, Table SI), none of which were likely pathogenic. Thus, we did not find any unequivocal pathogenic mutations in NLRP2 in the 11 mothers of diploid HMs with genomic contribution from both parents.
We discovered two different variations in C6orf221. Both are frequent and unlikely to be pathogenic and involved in PM mole ethiology.
Although we cannot exclude that in some of the women NLRP7, NLRP2 or C6orf221 was inactivated due to alterations in regulatory sequences or due to epigenetic changes, it seems that diploid moles with biparental contributions to the molar genome in general are not associated with inactivation of either of these genes in the mother.
In conclusion, the only women in our cohort of mothers to produce HMs with biparental alleles, that definitely carries pathogenic mutations in NRLP7 are the only women in the cohort that have FRHM. Thus, it is possible that mutations in the coding sequence of NLRP7 (and C6orf221) results in familial recurrent HM (FRHM) and that the etiologies behind isolated diploid HMs with biparental contributions to the molar genome including HMs showing mosaicism, are to be found elsewhere.
Our findings do not support the theory that NLRP7 mutations leads to an increased risk of androgenic pregnancies through a condition of mosaicism.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/.
